IP Library Granted Patent US 7,376,467
Granted Patent B2
US 7,376,467 · App. 11/056,591 · Granted May 20, 2008

Portable assemblies, systems and methods for providing functional or therapeutic neuromuscular stimulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,376,467
App. No.
11/056,591
Granted
May 20, 2008
Kind
B2
Abstract

Neuromuscular stimulation assemblies, systems, and methods make possible the providing of short-term therapy or diagnostic testing by providing electrical connections between muscles or nerves inside the body and stimulus generators or recording instruments mounted on the surface of the skin outside the body. Neuromuscular stimulation assemblies, systems, and methods may include a steerable introducer that defines an interior lumen sized and configured to shield a percutaneous electrode from contact with tissue during advancement to a desired position within tissue.

Claims (48)

1. A neuromuscular stimulation assembly comprising

a carrier sized and configured to be worn on the external skin surface, the carrier including a tissue facing surface,

at least one percutaneous electrode extending from the carrier,

circuitry carried on-board the carrier configured to generate a stimulation pulse to the electrode, and

the carrier tissue facing surface including a return electrode, the return electrode being coupled to the circuitry and in contact with the external skin surface.

2. An assembly according to claim 1

wherein the circuitry is removable from the carrier and replaceable.

3. An assembly according to claim 1

wherein the return electrode is a transcutaneous electrode.

4. An assembly according to claim 1

the carrier further including a power input bay sized and configured to hold a disposable battery for the circuitry that can be released and replaced for powering the circuitry,

instructions furnished by a clinician or caregiver or physician prescribing the release and replacement of the disposable battery according to a prescribed battery replacement regime, the prescribed battery replacement regime comprising the replacement of the disposable battery on a prescribed repeated basis similar to administering a pill under a prescribed pill-based medication regime, and

a supply of disposable batteries, each battery comprising a dose of power for the circuitry for administration according to the prescribed battery replacement regime.

5. A method of evaluating whether a person has an innervated muscle which responds to electrical stimulation comprising

providing a neuromuscular stimulation assembly comprising a carrier sized and configured to be worn on the external skin surface, the carrier including a tissue facing surface, at least one percutaneous electrode extending from the carrier, circuitry carried on-board the carrier configured to generate a stimulation pulse to the electrode, and the carrier tissue facing surface including a return electrode, the return electrode being coupled to the circuitry and in contact with the external skin surface,

placing the percutaneous electrode in association peripheral motor nerves that innervate the muscle,

placing the carrier on an external skin surface so the return electrode is in electrical contact with the external skin surface,

coupling the percutaneous electrode to the carrier, and

operating the circuitry to determine whether the person has an innervated muscle which responds to electrical stimulation.

6. A neuromuscular stimulation assembly comprising

at least one percutanous electrode sized and configured for stimulation of a targeted neural or muscular tissue region,

a carrier sized and configured to be worn on the external skin surface, the carrier including a tissue facing surface,

programmable circuitry carried on-board the carrier configured to generate a stimulation pulse,

the carrier tissue facing surface including a return electrode, the return electrode being coupled to the programmable circuitry and in contact with the external skin surface,

a power input bay carried on-board the carrier that is electrically coupled to the circuitry, and

an electrode connection element carried on-board the carrier that is electrically coupled to the circuitry, the electrode connection element being sized and configured to electrically couple the at least one electrode to the circuitry to apply the stimulation pulse to the tissue region.

7. An assembly according to claim 6

wherein the return electrode is a surface mounted return electrode.

8. An assembly according to claim 6

further including a communication bay carried on-board the carrier that is electrically coupled to the programmable circuitry, the communication bay being sized and configured to establish a wireless communication link between the circuitry and an external device.

9. An assembly according to claim 6

wherein the programmable circuitry is removable from the carrier and replaceable.

10. An assembly according to claim 6

wherein the power input bay is sized and configured to hold a disposable battery for the circuitry that can be released and replaced for powering the circuitry,

the assembly further including instructions furnished by a clinician or caregiver or physician prescribing the release and replacement of the disposable battery according to a prescribed battery replacement regime, the prescribed battery replacement regime comprising the replacement of the disposable battery on a prescribed repeated basis similar to administering a pill under a prescribed pill-based medication regime, and

a supply of disposable batteries, each battery comprising a dose of power for the circuitry for administration according to the prescribed battery replacement regime.

11. An assembly according to claim 4 or 10

wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a daily basis.

12. An assembly according to claim 4 or 10

wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a weekly basis.

13. A method for providing a neuromuscular stimulation function comprising

providing a neuromuscular stimulation assembly comprising a carrier sized and configured to be worn on the external skin surface, the carrier including a tissue facing surface and a power input bay, the power input bay being sized and configured to hold a disposable battery for the circuitry that can be released and replaced for powering the circuitry, at least one percutaneous electrode extending from the carrier, circuitry carried on-board the carrier configured to generate a stimulation pulse to the electrode, and the carrier tissue facing surface including a return electrode, the return electrode being coupled to the circuitry and in contact with the external skin surface,

providing instructions furnished by a clinician or caregiver or physician prescribing the release and replacement of the disposable battery according to a prescribed battery replacement regime, the prescribed battery replacement regime comprising the replacement of the disposable battery on a prescribed repeated basis similar to administering a pill under a prescribed pill-based medication regime, and

providing a supply of disposable batteries, each battery comprising a dose of power for the circuitry for administration according to the prescribed battery replacement regime.

14. A method according to claim 13

wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a daily basis.

15. A method according to claim 13

wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a weekly basis.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066526/0025 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066415/0750 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0676 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0721 →
CHANGE OF NAME Recorded Dec 6, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044716/0812 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044414/0575 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044715/0395 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 043746 FRAME: 0882. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 5, 2017
From: NDI MEDICAL, LLC
To: SPR THERAPEUTICS, LLC
Reel/Frame 044128/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2017
From: NDI MEDICAL, LLC
To: SPR THERAPEUTICE, LLC
Reel/Frame 043746/0882 →
SECURITY INTEREST Recorded Sep 24, 2014
From: SPR THERAPEUTICS, LLC
To: OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 033809/0771 →